The occurrence of rare cancers in U.S. adults, 1995-2004

Public Health Reports

Volumn 125, Issue 1, 2010, Pages 28-43

  Greenlee, Robert T ^a   Goodman, Marc T ^b   Lynch, Charles F ^c   Platz, Charles E ^d   Havener, Lori A ^e   Howe, Holly L ^e  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e North American Association of Central Cancer Registries   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER CLASSIFICATION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PREVENTION; CANCER REGISTRY; CLINICAL EVALUATION; COMPUTER PROGRAM; DEMOGRAPHY; DIGESTIVE SYSTEM CANCER; ENDOCRINE TUMOR; EYE CANCER; FEMALE; GROUPS BY AGE; GYNECOLOGIC CANCER; HEART CANCER; HISTOLOGY; HUMAN; JOINT CANCER; KAPOSI SARCOMA; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; MESOTHELIOMA; MOUTH CANCER; MYELOMA; NEOPLASM; NERVOUS SYSTEM TUMOR; ORBIT CANCER; PHARYNX CANCER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RARE CANCER; RESPIRATORY TRACT TUMOR; SKIN CANCER; SOFT TISSUE CANCER; UNITED STATES; URINARY TRACT CANCER;

EID: 74849131061     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491012500106     Document Type: Article

References (46)

1. Rare Diseases Act of 2002. Public law 107-280 [cited 2008 Sep 25]. Available from: URL: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname= 107-cong-public-laws&docid=f:publ280.107
2. National Cancer Institute Epidemiology and Genetics Research. Synergizing epidemiologic research on rare cancers, 2007 [cited 2008 Sep 25]. Available from: URL: http://epi.grants.cancer.gov/Synergizing/index.html
3. Walvekar RR, Kane SV, D'Cruz AK. Collision tumor of the thyroid: follicular variant of papillary carcinoma and squamous carcinoma. World J Surg Oncol 2006;4:65.
4. Fou A, Schabel FR, Hamele-Bena D, Wei XJ, Cheng B, El Tamer M, et al. Long-term outcomes of malignant phyllodes tumors patients: an institutional experience. Am J Surg 2006;192:492-5.
5. Oliveira DT, de Moraes RV, Filho J, Neto J, Landman G, Kowalski LP. Oral verrucous carcinoma: a retrospective study in Sao Paulo region, Brazil. Clin Oral Investig 2006;10:205-9.
6. Hassan R, Alexander R, Antman K, Boffetta P, Churg A, Coit D, et al. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol 2006;17:1615-9.
7. Podnos YD, Tsai NC, Smith D, Ellenhorn JD. Factors affecting survival in patients with anal melanoma. Am Surg 2006;72:917-20.
8. Joannides T. Rare cancers. Clin Oncol (R Coll Radiol) 2001;13:235.
9. National Cancer Institute. First NCI Epidemiology Leadership Workshop: tobacco, diet, and genes; 2004 Sep 19-21; Chicago [cited 2008 Sep 25]. Available from: URL: http://epi.grants.cancer.gov/Conference
10. National Cancer Institute. 2nd NCI Epidemiology Leadership Workshop: understudied rare cancers; 2005 Sep 11-13; Boston [cited 2008 Sep 25]. Available from: URL: http://epi.grants.cancer.gov/documents/Conference2/MeetingSummary. pdf
11. Tucker TC, Howe HL. Measuring the quality of population-based cancer registries: the NAACCR perspective. J Reg Manag 2001;28: 41-4.
12. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin LH, Parkin MD, editors. International classification of diseases for oncology, 3rd ed. Geneva: World Health Organization; 2000.
13. Surveillance Research Program, National Cancer Institute. SEER*Stat software: Version 6.3.6. Bethesda (MD): Surveillance Research Program, National Cancer Institute; 2007.
14. Fay MP. Approximate confidence intervals for rate ratios from directly standardized rates with sparse data. Communications in Statistics: Theory and Methods 1999;28:2141-60.
15. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al., editors. SEER cancer statistics review, 1975-2004. Bethesda (MD): National Cancer Institute; 2007. Also available from: URL: http://seer.cancer.gov/csr/ 1975-2004 [cited 2008 Sep 25].
16. Department of Health and Human Services (US), Office of Rare Diseases, National Institutes of Health. Annual report on the rare diseases research activities at the National Institutes of Health, FY 2005. 2006 [cited 2008 Sep 25]. Available from: URL: http://rarediseases.info.nih.gov/asp/html/reports/ fy2005/Annual-Report-FY-05-Final.pdf
17. Very rare cancers-a problem neglected. Lancet Oncol 2001;2:189.
18. US Cancer Statistics Working Group. United States cancer statistics: 1999-2004 incidence and mortality Web-based report. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention (US), National Cancer Institute; 2007. Also available from: URL: www.cdc.gov/uscs [cited 2007 Dec 21].
19. Zeig-Owens R, Knowlton R, Gershman ST, Howe HL. CINA highlights of cancer incidence and mortality in the United States and Canada, 2000-2004. Springfield (IL): North American Association of Central Cancer Registries, Inc.; October 2007.
20. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 2008;8:288-98.
21. Keppel KG. Ten largest racial and ethnic health disparities in the United States based on Healthy People 2010 objectives. Am J Epidemiol 2007;166:97-103.
22. Chu KC, Miller BA, Springfield SA. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc 2007;99:1092-100, 1102-4.
23. Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, et al. Personal sun exposure and risk of non-Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 2008;122:144-54.
24. Weber DC, Miller RC, Villa S, Hanssens P, Baumert BG, Castadot P, et al. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2006;66:179-86.
25. Zurriaga Llorens O, Martinez Garcia C, Arizo Luque V, Sanchez Perez MJ, Ramos Aceitero JM, Garcia Blasco MJ, et al. [Disease registries in the epidemiological researching of rare diseases in Spain]. Rev Esp Salud Publica 2006;80:249-57.
26. Schon D, Bertz J, Gorsch B, Haberland J, Kurth BM. [Federal Cancer Reporting Unit. Surveillance program for cancer registration in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004;47:429-36.
27. Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathological predictors of survival in 1,252 cases. Cancer 2006;107:2134-42.
28. Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 2006;30:872-8.
29. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 2006;106:1610-6.
30. Improvements needed for adolescents and young adults. NCI Cancer Bulletin 2008;5:10. Also available from: URL: http://www.cancer.gov/ncicancerbulletin/ NCI-Cancer-Bulletin-031808/page10[cited 2008 Sep 25].
31. Howe HL, Hinds RA, editors. NAACCR annotated bibliography of research and publications: multi-registry cancer incidence and mortality studies in the United States and Canada, April 2008. Springfield (IL): North American Association of Central Cancer Registries, Inc.; 2007.
32. Goodman MT, Yamamoto J. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002. Cancer Causes Control 2007;18:415-22.
33. Goodman MT, Hernandez BY, Shvetsov YB. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003. Cancer Epidemiol Biomarkers Prev 2007;16:1833-9.
34. Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control 2008;19:379-90.
35. Roffers SD, Wu XC, Johnson CH, Correa CN. Incidence of extraovarian primary cancers in the United States, 1992-1997. Cancer 2003;97(10 Suppl):S2643-7.
36. Wingo PA, Jamison PM, Young JL, Gargiullo P. Population-based statistics for women diagnosed with inflammatory breast cancer. Cancer Causes Control 2004;15:321-8.
37. Young JL Jr, Ward KC, Wingo PA, Howe HL. The incidence of malignant non-carcinomas of the female breast. Cancer Causes Control 2004;15:313-9.
38. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the US Cancer 2005;103:1000-7.
39. Thomas RM, Sobin LH. Gastrointestinal cancer. Cancer 1995;75(1 Suppl):S154-70.
40. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a metaanalysis. Br J Cancer 2003;88:63-73.
41. Liu CY, Wang MC, Li WY, Chang SY, Chu PY. Sarcoma of the larynx: treatment results and literature review. J Chin Med Assoc 2006;69:120-4.
42. Goodman MT, Tung KH, Wilkens LR. Comparative epidemiology of breast cancer among men and women in the US, 1996 to 2000. Cancer Causes Control 2006;17:127-36.
43. McCusker ME, Cote TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the Surveillance, Epidemiology, and End-Results program, 1973-1998. Cancer 2002;94:3307-12.
44. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-59.
45. Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695-708.
46. Chen VW, Ruiz B, Kileen JL, Cote TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer 2003;97(10 Suppl): S2631-42.